GOLDSTONE ASIA PHARM: Expected net profit in the first half of the year to grow by 50.04%-85.24% year-on-year
GOLDSTONE ASIA PHARM announced that it expects a net profit of RMB 58.8172 million to RMB 72.6178 million in the first half of 2025, an increase of 50.04% to 85.24% compared to RMB 39.2022 million in the same period last year
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments